Zydus Applies to the DCGI for EUA to Launch ZyCoV-D

AHMEDABAD:Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to.

Regulatory Nod for Conducting Clinical Trials of Colchicine on COVID-19 Patients: CSIR

NEW DELHI:The Drugs Controller General of India (DCGI) has given approval to the CSIR and.

Russia’s Sputnik V Covid-19 Vaccine Claimed To Be 95% Effective

MOSCOW:Russia’s Sputnik V vaccine has been found to be more than 95 per cent effective.

PNB Vesper Obtains Permission to Test its New Chemical Entity PNB 001 in COVID-19 Patients

KOCHI:PNB Vesper life science Pvt Ltd, is a leading Indian Pharma Research company with a.

COVID-19: India”s Testing Rate Lower than Other Nations, says WHO Chief Scientist

HYDERABAD: Noting that lockdown was a temporary measure to contain the spread of coronavirus, a.

Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir

KOCHI: Glenmark Pharmaceuticals Ltd. – a global research-led pharmaceutical company – today announced top-line results.

Glenmark Commences 1000 Patients Post Marketing Surveillance Study with COVID-19

KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced.

Pankajakasthuri Promising Interim Results for ZingiVir–H Among COVID-19 Patients

THIRUVANANTHAPURAM: Pankajakasthuri Herbals India Private Limited (PKHIL) today announced promising interim clinical trial results for.

‘Antiviral Agents’ Most Effective Therapeutic Option for COVID-19

MUMBAI: Course5 Intelligence, a leading analytics and AI solutions provider headquartered in India, today released.

Plasma Bank to be Set up in Delhi for Treatment of COVID-19 Patients

NEW DELHI: Delhi Chief Minister Arvind Kejriwal on Monday announced setting up of a ”plasma.